The Medicines Company (MDCO) Ph3 ORION-11 Data Impresses, PT to $60 at Oppenheimer
Tweet Send to a Friend
Oppenheimer analyst Jay Olson reiterated an Outperform rating on The Medicines ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
